S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.49 (-3.35%)
BABA   72.33 (+1.17%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.22%)
MU   73.65 (+0.71%)
CGC   0.72 (+3.57%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.49 (-3.35%)
BABA   72.33 (+1.17%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.22%)
MU   73.65 (+0.71%)
CGC   0.72 (+3.57%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.49 (-3.35%)
BABA   72.33 (+1.17%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.22%)
MU   73.65 (+0.71%)
CGC   0.72 (+3.57%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.49 (-3.35%)
BABA   72.33 (+1.17%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.22%)
MU   73.65 (+0.71%)
CGC   0.72 (+3.57%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)

Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News

$31.48
+0.05 (+0.16%)
(As of 04:28 PM ET)
Compare
Today's Range
$31.27
▼
$31.48
50-Day Range
$28.58
▼
$31.52
52-Week Range
$28.58
▼
$33.53
Volume
842 shs
Average Volume
1,801 shs
Market Capitalization
$12.59 million
Assets Under Management
$12.58 million
Dividend Yield
1.27%
Net Expense Ratio
0.84%
Stock AnalysisChartHeadlinesHoldingsOwnershipRatings

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.

BOUT Stock Price History

BOUT ETF News Headlines

September 11, 2023 | finance.yahoo.com
BOUT - Innovator IBD Breakout Opportunities ETF
July 30, 2023 | morningstar.com
Innovator ETFs
December 7, 2023 | Edge On The Street (Ad)
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
July 25, 2023 | seekingalpha.com
NUGO Nuveen Growth Opportunities ETF
May 10, 2023 | benzinga.com
Innovator IBD Breakout Opportunities ETF (ARCA:BOUT), Quotes and News Summary
March 22, 2023 | seekingalpha.com
BOUT Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF
March 1, 2023 | seekingalpha.com
FFTY Innovator IBD 50 Fund
December 20, 2022 | thestreet.com
Innovator IBD(R) Breakout Opportunities ETF
December 7, 2023 | Edge On The Street (Ad)
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
January 23, 2022 | nasdaq.com
Innovator IBD Breakout Opportunities ETF (BOUT)
See More Headlines
Receive BOUT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Innovator Capital Management
Fund Name
Innovator IBD Breakout Opportunities ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:BOUT
Inception Date
9/13/2018
Fund Manager
Dustin Lewellyn, Ernesto Tong, Anand Desai
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
IBD Breakout Stocks Index
Category
Broad Equity
Focus
Strategy
Development Level
Developed Markets
Region
North America
Number of Holdings
114

Fund Statistics

Assets Under Management
$12.58 million
Average Daily Volume
$1,042.40
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Innovator Capital Management, LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
200 shs

Miscellaneous

Outstanding Shares
400,000
Beta
0.98
Creation Unit
50,000
Creation Fee
$250.00
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Innovator IBD Breakout Opportunities ETF Expenses

TypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.80%0.46%0.53%0.50%0.51%
Other Expenses0.04%0.40%0.54%0.64%0.57%
Total Expense0.84%0.60%0.70%0.73%0.70%
Fee Waiver0.00%-0.45%-0.54%-0.69%-0.57%
Net Expense0.84%0.50%0.60%0.57%0.57%

Innovator IBD Breakout Opportunities ETF (BOUT) Holdings & Exposure

Top 10 BOUT Holdings

BOUT Sector Exposure

BOUT Industry Exposure

Full Holdings Details














BOUT ETF - Frequently Asked Questions

How have BOUT shares performed in 2023?

Innovator IBD Breakout Opportunities ETF's stock was trading at $29.5835 at the beginning of the year. Since then, BOUT stock has increased by 6.4% and is now trading at $31.48.
View the best growth stocks for 2023 here.

What does BOUT invest in?

Innovator IBD Breakout Opportunities ETF is a equity fund issued by Innovator Capital Management. BOUT focuses on strategy investments and follows the IBD Breakout Stocks Index. The fund's investments total to approximately $12.58 million assets under management.

What stocks does Innovator IBD Breakout Opportunities ETF hold?

BOUT invests in 114 holdings. Some of the stocks in their portfolio include Terex (TEX), Arrow Electronics (ARW), Deere & Company (DE), Digi International (DGII), Main Street Capital (MAIN), IMAX (IMAX), RH (RH), Acelyrin (SLRN), NetEase (NTES) and BOX (BOX).

What is the management fee for Innovator IBD Breakout Opportunities ETF?

Innovator IBD Breakout Opportunities ETF's management fee is 0.80% and has other expenses of 0.04%. The net expense ratio for BOUT is 0.84%.

How do I buy shares of Innovator IBD Breakout Opportunities ETF?

Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEARCA:BOUT) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -